Comparison
Citicoline vs Curcumin
Side-by-side of Citicoline and Curcumin. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
Citicoline
Citicoline supplement profile: CDP-choline as a phosphatidylcholine precursor, Cognizin dosing 250-2000 mg, cognition trials, stroke recovery evidence.
Curcumin
Curcumin supplement guide: turmeric extract at 500-1000 mg/day, piperine and Meriva for absorption, evidence in joint inflammation and mood.
Effects at a glance
Citicoline
- •Choline donor and phosphatidylcholine precursor; oral bioavailability roughly 99%
- •Standard prescription medication for stroke recovery and vascular cognitive impairment in much of the world
- •Healthy-adult cognitive trials (Cognizin) report small gains in attention and working memory at 250 to 500 mg/day
- •ICTUS trial (n=2,298) was negative on stroke recovery in the modern thrombolysis era
- •Lower per-gram choline content than alpha-GPC (~18% vs ~40%), meaning smaller TMAO load at equivalent dose
- •Long uridine half-life (~56 hours) supports once or twice daily dosing
Curcumin
- •Reduces osteoarthritis knee pain comparable to ibuprofen at 1500 mg/day enhanced formulation
- •Modest antidepressant effect (SMD ~0.34) as monotherapy or SSRI adjunct in major depression
- •Standard curcumin has ~3% bioavailability; Meriva, BCM-95, Theracurmin shift absorption 5-30 fold
- •Inhibits NF-kB and COX-2; reduces hs-CRP, IL-6, TNF-alpha in chronic inflammation
- •Antiplatelet effect at higher doses; meaningful interaction with warfarin and DOACs
- •Iron chelation can contribute to deficiency in already-marginal patients
Side-by-side
| Attribute | Citicoline | Curcumin |
|---|---|---|
| Category | supplement | natural |
| Also known as | CDP-choline, cytidine 5'-diphosphocholine, Cognizin | turmeric extract, diferuloylmethane |
| Half-life (hr) ↗ | 56 | 7 |
| Typical dose (mg) ↗ | 500 | 500 |
| Dosing frequency | 1 to 2 times daily | 1 to 2 times daily with meals |
| Routes | oral, intravenous | oral |
| Onset (hr) | 1 | 2 |
| Peak (hr) | 2 | 4 |
| Molecular weight | 488.32 | 368.38 |
| Molecular formula | C14H26N4O11P2 | C21H20O6 |
| Mechanism | Hydrolyzed to cytidine and choline after absorption; both cross the blood-brain barrier and are recombined intracellularly to reform CDP-choline, supporting phosphatidylcholine synthesis and acetylcholine production. | Inhibits NF-kB transcription factor, COX-2, and lipoxygenase; activates AMPK and Nrf2; modulates JAK-STAT and PI3K-Akt kinase signaling. Pleiotropic anti-inflammatory and antioxidant effects. |
| Legal status | Dietary supplement (US, Cognizin GRAS); prescription medication in most of the world | Dietary supplement (global) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement (US); Rx in most of the world | Not scheduled |
| Pregnancy | Insufficient data for routine use | Culinary turmeric is safe; supplemental curcumin best avoided in pregnancy |
| CAS | 987-78-0 | 458-37-7 |
| PubChem CID | 13804 | 969516 |
| Wikidata | Q411470 | Q312266 |
Safety profile
Citicoline
Common side effects
- mild GI upset
- headache
- restlessness
- occasional insomnia with evening dosing
Contraindications
- concurrent strong anticholinergic therapy
- established cardiovascular disease (TMAO concern, smaller than alpha-GPC)
Interactions
- anticholinergic medications: partial mutual antagonism(minor)
- cholinesterase inhibitors: additive cholinergic effect(minor)
- antimetabolite chemotherapy (5-FU): theoretical cytidine pathway interaction(minor)
Curcumin
Common side effects
- nausea
- diarrhea
- dyspepsia
- yellow stool (benign)
Contraindications
- active gallstones (curcumin stimulates gallbladder contraction)
- severe biliary obstruction
- scheduled elective surgery (discontinue 1-2 weeks prior)
Interactions
- warfarin and DOACs: additive antiplatelet and anticoagulant effects; meaningful bleeding risk at 1000+ mg/day(major)
- aspirin and NSAIDs: additive antiplatelet effect(moderate)
- tacrolimus and cyclosporine: CYP3A4 and P-gp modulation may alter drug levels(moderate)
- iron supplements: curcumin chelates iron; can contribute to deficiency in marginal patients(moderate)
- chemotherapy agents: potential interference with multiple agents; coordinate with oncology team(major)
Which Should You Take?
Citicoline and Curcumin score evenly on the criteria we weight (goal breadth, legal accessibility, evidence depth). The conditionals below should drive the decision more than any aggregate score.
- → If your priority is focus or working memory, pick Citicoline.
- → If your priority is stroke recovery, pick Citicoline.
- → If your priority is post-training recovery, pick Curcumin.
- → If your priority is healthspan extension, pick Curcumin.
Edge case: Half-lives differ materially (Citicoline ~56 hr vs Curcumin ~7 hr). Citicoline reaches steady state faster; Curcumin is easier to dial in if tolerability is uncertain.
Default choice: either is defensible. Citicoline edges out on goal breadth + legal accessibility; Curcumin is the right call if your priority sits in the goals listed above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between Citicoline and Curcumin?
Citicoline and Curcumin differ in category (supplement vs natural), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, Citicoline or Curcumin?
Citicoline half-life is 56 hours; Curcumin half-life is 7 hours.
Can you stack Citicoline with Curcumin?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper